Literature DB >> 21454498

Structural study of the complex stereoselectivity of human butyrylcholinesterase for the neurotoxic V-agents.

Marielle Wandhammer1, Eugénie Carletti, Marcel Van der Schans, Emilie Gillon, Yvain Nicolet, Patrick Masson, Maurice Goeldner, Daan Noort, Florian Nachon.   

Abstract

Nerve agents are chiral organophosphate compounds (OPs) that exert their acute toxicity by phosphorylating the catalytic serine of acetylcholinesterase (AChE). The inhibited cholinesterases can be reactivated using oximes, but a spontaneous time-dependent process called aging alters the adduct, leading to resistance toward oxime reactivation. Human butyrylcholinesterase (BChE) functions as a bioscavenger, protecting the cholinergic system against OPs. The stereoselectivity of BChE is an important parameter for its efficiency at scavenging the most toxic OPs enantiomer for AChE. Crystals of BChE inhibited in solution or in cristallo with racemic V-agents (VX, Russian VX, and Chinese VX) systematically show the formation of the P(S) adduct. In this configuration, no catalysis of aging seems possible as confirmed by the three-dimensional structures of the three conjugates incubated over a period exceeding a week. Crystals of BChE soaked in optically pure VX(R)-(+) and VX(S)-(-) solutions lead to the formation of the P(S) and P(R) adduct, respectively. These structural data support an in-line phosphonylation mechanism. Additionally, they show that BChE reacts with VX(R)-(+) in the presence of racemic mixture of V-agents, at odds with earlier kinetic results showing a moderate higher inhibition rate for VX(S)-(-). These combined results suggest that the simultaneous presence of both enantiomers alters the enzyme stereoselectivity. In summary, the three-dimensional data show that BChE reacts preferentially with P(R) enantiomer of V-agents and does not age, in complete contrast to AChE, which is selectively inhibited by the P(S) enantiomer and ages.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21454498      PMCID: PMC3089521          DOI: 10.1074/jbc.M110.209569

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

1.  Pharmacology of organophosphorus cholinesterase inhibitors.

Authors:  B HOLMSTEDT
Journal:  Pharmacol Rev       Date:  1959-09       Impact factor: 25.468

2.  X-ray crystallographic snapshots of reaction intermediates in the G117H mutant of human butyrylcholinesterase, a nerve agent target engineered into a catalytic bioscavenger.

Authors:  Florian Nachon; Eugenie Carletti; Marielle Wandhammer; Yvain Nicolet; Lawrence M Schopfer; Patrick Masson; Oksana Lockridge
Journal:  Biochem J       Date:  2011-02-15       Impact factor: 3.857

3.  Differences between some biological properties of enantiomers of alkyl S-alkyl methylphosphonothioates.

Authors:  C R Hall; T D Inch; R H Inns; A W Muir; D J Sellers; A P Smith
Journal:  J Pharm Pharmacol       Date:  1977-09       Impact factor: 3.765

4.  Comparison of polyethylene glycol-conjugated recombinant human acetylcholinesterase and serum human butyrylcholinesterase as bioscavengers of organophosphate compounds.

Authors:  Ofer Cohen; Chanoch Kronman; Lily Raveh; Ohad Mazor; Arie Ordentlich; Avigdor Shafferman
Journal:  Mol Pharmacol       Date:  2006-06-26       Impact factor: 4.436

5.  Protection against soman or VX poisoning by human butyrylcholinesterase in guinea pigs and cynomolgus monkeys.

Authors:  David E Lenz; Donald M Maxwell; Irwin Koplovitz; Connie R Clark; Benjamin R Capacio; Douglas M Cerasoli; James M Federko; Chunyuan Luo; Ashima Saxena; Bhupendra P Doctor; Carl Olson
Journal:  Chem Biol Interact       Date:  2005-11-09       Impact factor: 5.192

Review 6.  Acetylcholinesterase: 'classical' and 'non-classical' functions and pharmacology.

Authors:  Israel Silman; Joel L Sussman
Journal:  Curr Opin Pharmacol       Date:  2005-06       Impact factor: 5.547

7.  Exploring the active center of human acetylcholinesterase with stereomers of an organophosphorus inhibitor with two chiral centers.

Authors:  A Ordentlich; D Barak; C Kronman; H P Benschop; L P De Jong; N Ariel; R Barak; Y Segall; B Velan; A Shafferman
Journal:  Biochemistry       Date:  1999-03-09       Impact factor: 3.162

Review 8.  Butyrylcholinesterase for protection from organophosphorus poisons: catalytic complexities and hysteretic behavior.

Authors:  Patrick Masson; Oksana Lockridge
Journal:  Arch Biochem Biophys       Date:  2009-12-11       Impact factor: 4.013

9.  Suitability of human butyrylcholinesterase as therapeutic marker and pseudo catalytic scavenger in organophosphate poisoning: a kinetic analysis.

Authors:  N Aurbek; H Thiermann; F Eyer; P Eyer; F Worek
Journal:  Toxicology       Date:  2009-03-06       Impact factor: 4.221

10.  Aging pathways for organophosphate-inhibited human butyrylcholinesterase, including novel pathways for isomalathion, resolved by mass spectrometry.

Authors:  He Li; Lawrence M Schopfer; Florian Nachon; Marie-Thérèse Froment; Patrick Masson; Oksana Lockridge
Journal:  Toxicol Sci       Date:  2007-08-13       Impact factor: 4.849

View more
  10 in total

1.  Fundamental reaction pathway and free energy profile for butyrylcholinesterase-catalyzed hydrolysis of heroin.

Authors:  Yan Qiao; Keli Han; Chang-Guo Zhan
Journal:  Biochemistry       Date:  2013-08-30       Impact factor: 3.162

2.  Decline in serum cholinesterase activities predicts 2-year major adverse cardiac events.

Authors:  Yaron Arbel; Shani Shenhar-Tsarfaty; Nir Waiskopf; Ariel Finkelstein; Amir Halkin; Miri Revivo; Shlomo Berliner; Itzhak Herz; Itzhak Shapira; Gad Keren; Hermona Soreq; Shmuel Banai
Journal:  Mol Med       Date:  2014-02-12       Impact factor: 6.354

3.  Understanding the enzyme-ligand complex: insights from all-atom simulations of butyrylcholinesterase inhibition.

Authors:  Walter Alvarado; Parker Ladd Bremer; Angela Choy; Helen N Dinh; Aingty Eung; Jeannette Gonzalez; Phillippe Ly; Trina Tran; Kensaku Nakayama; Jason P Schwans; Eric J Sorin
Journal:  J Biomol Struct Dyn       Date:  2019-04-07

4.  Detoxification of Organophosphate Poisoning Using Nanoparticle Bioscavengers.

Authors:  Zhiqing Pang; Che-Ming J Hu; Ronnie H Fang; Brian T Luk; Weiwei Gao; Fei Wang; Erdembileg Chuluun; Pavimol Angsantikul; Soracha Thamphiwatana; Weiyue Lu; Xinguo Jiang; Liangfang Zhang
Journal:  ACS Nano       Date:  2015-06-08       Impact factor: 15.881

5.  Reaction pathways and free energy profiles for cholinesterase-catalyzed hydrolysis of 6-monoacetylmorphine.

Authors:  Yan Qiao; Keli Han; Chang-Guo Zhan
Journal:  Org Biomol Chem       Date:  2014-04-14       Impact factor: 3.876

6.  Differences in anti-malarial activity of 4-aminoalcohol quinoline enantiomers and investigation of the presumed underlying mechanism of action.

Authors:  Catherine Mullié; Alexia Jonet; Camille Desgrouas; Nicolas Taudon; Pascal Sonnet
Journal:  Malar J       Date:  2012-03-08       Impact factor: 2.979

7.  Optimization of Cholinesterase-Based Catalytic Bioscavengers Against Organophosphorus Agents.

Authors:  Sofya V Lushchekina; Lawrence M Schopfer; Bella L Grigorenko; Alexander V Nemukhin; Sergei D Varfolomeev; Oksana Lockridge; Patrick Masson
Journal:  Front Pharmacol       Date:  2018-03-13       Impact factor: 5.810

8.  Comparison of the Binding of Reversible Inhibitors to Human Butyrylcholinesterase and Acetylcholinesterase: A Crystallographic, Kinetic and Calorimetric Study.

Authors:  Terrone L Rosenberry; Xavier Brazzolotto; Ian R Macdonald; Marielle Wandhammer; Marie Trovaslet-Leroy; Sultan Darvesh; Florian Nachon
Journal:  Molecules       Date:  2017-11-29       Impact factor: 4.411

9.  SAMPL7 protein-ligand challenge: A community-wide evaluation of computational methods against fragment screening and pose-prediction.

Authors:  Harold Grosjean; Mehtap Işık; Anthony Aimon; David Mobley; John Chodera; Frank von Delft; Philip C Biggin
Journal:  J Comput Aided Mol Des       Date:  2022-04-15       Impact factor: 4.179

10.  A Second Look at the Crystal Structures of Drosophila melanogaster Acetylcholinesterase in Complex with Tacrine Derivatives Provides Insights Concerning Catalytic Intermediates and the Design of Specific Insecticides.

Authors:  Florian Nachon; Terrone L Rosenberry; Israel Silman; Joel L Sussman
Journal:  Molecules       Date:  2020-03-06       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.